Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation Shahrokh Taghavi, MD, Andreas Zuckermann, MD, Jan Ankersmit, MD, Georg Wieselthaler, MD, Angela Rajek, MD, Günther Laufer, MD, Ernst Wolner, MD, Michael Grimm, MD The Annals of Thoracic Surgery Volume 78, Issue 5, Pages 1644-1649 (November 2004) DOI: 10.1016/j.athoracsur.2004.04.059
Fig 1 Kaplan-Meier analysis of overall survival of heart transplant recipients who required mechanical circulatory support (right ventricular assist device and extracorporeal membrane oxygenation) for right ventricular failure. Numbers in brackets represent patients at risk. The Annals of Thoracic Surgery 2004 78, 1644-1649DOI: (10.1016/j.athoracsur.2004.04.059)
Fig 2 Kaplan-Meier analysis of graft survival in heart transplant recipients who required mechanical circulatory support (either right ventricular assist device [RVAD] or extracorporeal membrane oxygenation [ECMO]) for right ventricular failure. Numbers in brackets represent patients at risk. (p = 0.005 by log-rank analysis.) The Annals of Thoracic Surgery 2004 78, 1644-1649DOI: (10.1016/j.athoracsur.2004.04.059)